Adenosine dry powder inhalation for bronchial challenge testing, part 2: Proof of concept in asthmatic subjects

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 1, 2014, Pages 148-152

  Lexmond, Anne J ^a   Van Der Wiel, Erica ^b   Hagedoorn, Paul ^a   Bult, Wouter ^b   Frijlink, Henderik W ^a   Ten Hacken, Nick H T ^b   De Boer, Anne H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adenosine; Adenosine 5 monophosphate; Asthma; Bronchial challenge test; Bronchial hyperresponsiveness; Dry powder inhaler

Indexed keywords

EID: 84899771161     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.04.008     Document Type: Article

References (15)

1. D.W. Cockcroft Provocation methods: direct challenges Clin. Rev. Allergy Immunol. 24 2003 19 26
2. M. Van den Berge, R.J. Meijer, and H.A.M. Kerstjens PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine Am. J. Resp. Crit. Care Med. 165 5 2002 1546 1550
3. 1 Am. J. Resp. Crit. Care Med. 165 2002 327 331
4. J. Cohen, D.S. Postma, W.R. Douma, J.M. Vonk, A.H. De Boer, and N.H.T. ten Hacken Particle size matters: diagnostics and treatment of small airways involvement in asthma Eur. Resp. J. 37 3 2011 532 540
5. G.F. Joos, and B. O'Connor Indirect airway challenges Eur. Resp. J. 21 6 2003 1050 1068
6. A.J. Lexmond, P. Hagedoorn, H.W. Frijlink, and A.H. de Boer Challenging the two-minute tidal breathing challenge test J. Aerosol. Med. Pulm. Drug Deliv. 26 2013 1 7
7. M.A. Martínez-García, M. Perpiñá-Tordera, V. Vila, L. Compte-Torrero, A. De Diego-Damiá, and V. Macián-Gisbert Analysis of the stability of stored adenosine 5′-monophosphate used for bronchoprovocation Pulm. Pharmacol. Ther. 15 2 2002 157 160
8. O.S. Usmani, M.F. Biddiscombe, and P.J. Barnes Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size Am. J. Resp. Crit. Care Med. 172 12 2005 1497 1504
9. A.J. Lexmond, P. Hagedoorn, E. van der Wiel, N.H.T. Ten Hacken, H.W. Frijlink, and A.H. de Boer Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testing Eur. J. Pharm. Biopharm. 86 1 2014 105 114
10. A.H. De Boer, P. Hagedoorn, D. Gjaltema, J. Goede, and H.W. Frijlink Air classifier technology (ACT) in dry powder inhalation Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures Int. J. Pharm. 260 2 2003 187 200
11. A.H. De Boer, P. Hagedoorn, E.M. Westerman, P.P.H. Le Brun, H.G.M. Heijerman, and H.W. Frijlink Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses Eur. J. Pharm. Sci. 28 3 2006 171 178
12. P.J. Sterk, L.M. Fabbri, and P.H. Quanjer Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults Eur. Resp. J. 6 Suppl. 16 1993 53 83
13. R.O. Crapo, R. Casaburi, and A.L. Coates American Thoracic Society guidelines for methacholine and exercise challenge testing - 1999 Am. J. Resp. Crit. Care Med. 161 2000 309 329
14. G. Borg Borg's Perceived Exertion and Pain Scales 1998 Human Kinetics Publishers Champaign
15. P. Quanjer, G. Tammeling, J. Cotes, O. Pedersen, R. Peslin, and J. Yernault Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur. Resp. J. Suppl. 16 1993 5 40